TBPH Theravance Biopharma, Inc.
$17.01▼ -0.06%
Healthcare
Other
After hours
$17.01▲ +0.00%
Sep 11, 7:30 PM ET
Volume 420.5K
Avg Volume (10D) 403.6K
Key Metrics & Fundamentals
Market Cap
$883.14M
P/E Ratio
16.4
Div Yield
–%
52W Range
13.08 - 21.03
% vs 50 MA
0.35%
% vs 200 MA
-1.48%
RSI-14
52.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.52
Free Cash Flow
-$6.97M
Gross Rev
$20.73M
Gross Profit
$20.73M
EBITDA
$5.84M
COGS
–
Operating Exp
$18.89M
Operating Income
$1.84M
EBIT
$1.84M
Pretax Income
-$4.79M
Net Income
-$5.90M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
Theravance Bio (TBPH) Up 0.8% Since Last Earnings Report: Can It Continue?
Zacks · Sep 9, 2026 3:30 PM
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks
Zacks · Aug 11, 2026 1:30 PM
Theravance Biopharma Swings to Net Loss in Q2, Revenue Falls
MT Newswires · Aug 10, 2026 12:59 PM
Theravance Bio: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 12:37 PM
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · Aug 10, 2026 12:30 PM
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 6, 2026 11:10 PM
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 6, 2026 8:05 PM
Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 3, 2026 12:10 PM
Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates
Zacks · Jul 30, 2026 9:15 PM
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
GlobeNewswire · Jul 16, 2026 10:00 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See TBPH's money flow as a full page
Social Sentiment
No Reddit posts found for TBPH.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.